Novartis
NVS
NVS
1,132 hedge funds and large institutions have $20.4B invested in Novartis in 2020 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 423 increasing their positions, 456 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,132
Holders Change
-39
Holders Change %
-3.33%
% of All Funds
25.01%
Holding in Top 10
30
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+30.43%
% of All Funds
0.66%
New
87
Increased
423
Reduced
456
Closed
110
Calls
$158M
Puts
$107M
Net Calls
+$50.7M
Net Calls Change
-$20.4M
Top Buyers
| 1 |
Charles Schwab
San Francisco,
California
|
+$357M |
| 2 |
Renaissance Technologies
New York
|
+$156M |
| 3 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$139M |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$129M |
| 5 |
FAM
Fred Alger Management
New York
|
+$85.4M |
Top Sellers
| 1 |
CSIA
Charles Schwab Investment Advisory
San Francisco,
California
|
-$417M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$384M |
| 3 |
BlackRock
New York
|
-$281M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$240M |
| 5 |
Jennison Associates
New York
|
-$217M |
